In the current study, we observed that NAP1L5 overexpression markedly reduced phospho-Tau Ser396 and Thr231 in N2a-APP695sw cells, indicating that NAP1L5 overexpression could alleviate the tauopathies of AD. This evidence concerns the gene MAPT and Alzheimer disease.